Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNYNF) Convertible Debt (2020 - 2021)

Historic Convertible Debt for Sanofi (SNYNF) over the last 2 years, with Q2 2021 value amounting to $24.4 billion.

  • Sanofi's Convertible Debt changed N/A to $24.4 billion in Q2 2021 from the same period last year, while for Jun 2021 it was $24.4 billion, marking a year-over-year change of. This contributed to the annual value of $25.8 billion for FY2020, which is N/A changed from last year.
  • As of Q2 2021, Sanofi's Convertible Debt stood at $24.4 billion.
  • Sanofi's Convertible Debt's 5-year high stood at $27.0 billion during Q4 2020, with a 5-year trough of $24.4 billion in Q2 2021.